1. Allen ME. The hematologic and immune systems. In: Wright JE, Shelton BK, editors. Desk reference for critical care nurses. 1st ed. Woods Hole, MA: Jones & Bartlett; 1993. p. 1131–45.
2. Atkinson TP, Kaliner MS. Anaphylaxis. Med Clin North Am. 1992;76:841–55.
3. Bellmunt J, Szczylik C, Feingold J, et al. Temsirolimus safety profile and management of toxic effects in patients with advanced renal cell carcinoma and poor prognostic features. Ann Oncol. 2008;19:1387–92.
4. Benesch M, Siegler N, von Hoff K, et al. Safety and toxicity of intrathecal liposomal cytarabine (Depocyte) in children and adolescents with recurrent or refractory brain tumors: a multi-institutional retrospective study. Anticancer Drugs. 2009;20:794–9.
5. Cancer Facts & Figures 2013. American Cancer Society website. http://www.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2013/index . Accessed 26 Dec 2013.